Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 19.48 USD -3.33%
Market Cap: 1.4B USD

Nurix Therapeutics Inc
Investor Relations

Nestled in the heart of the biotechnology wave, Nurix Therapeutics Inc. emerges as a pioneer in the burgeoning field of protein modulation. Founded with the ambition to transform drug discovery, the company focuses on manipulating the body’s complex system of protein degradation. Their mission orbits around harnessing the ubiquitin-proteasome system, a natural cellular process responsible for degrading unwanted proteins. Through this sophisticated dance of molecule manipulation, Nurix endeavors to tackle diseases that have eluded traditional drug discovery methods, aiming to control the fate of disease-causing proteins within the cellular ecosystem.

Nurix’s business model thrives on a dual approach: proprietary drug development and strategic collaborations. The company pursues its own pipeline of novel therapeutics targeting oncology and immunology, seeking breakthroughs that could redefine treatments for cancer and immune-related diseases. Simultaneously, it partners with pharmaceutical giants, leveraging its DUB (Deubiquitinase) platform technology in exchange for upfront payments, research funding, and potential milestones. This hybrid strategy not only diversifies their revenue streams but also amplifies their scientific influence, positioning them as a vital contributor to the evolving landscape of biopharmaceutical innovation. Through these finely-tuned processes, Nurix crafts its path in the highly competitive biotech arena, striving to turn cutting-edge science into tangible healthcare solutions.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Dr. Arthur T. Sands M.D., Ph.D.
CEO, President & Director
No Bio Available
Mr. Johannes Van Houte
Chief Financial Officer
No Bio Available
Dr. Gwenn M. Hansen Ph.D.
Chief Scientific Officer
No Bio Available
Dr. Arthur Weiss M.D., Ph.D.
Founder & Member of Scientific Advisory Board
No Bio Available
Rita Kwong
Senior Accounting Manager
No Bio Available
Dr. Pasit Phiasivongsa Ph.D.
Chief Technical Officer
No Bio Available
Dr. Christine Ring J.D., Ph.D.
Chief Legal Officer, Secretary & Chief Compliance Officer
No Bio Available
Mr. Eric C. Schlezinger J.D.
Chief People Officer
No Bio Available

Contacts

Address
CALIFORNIA
San Francisco
1700 Owens St Ste 205
Contacts
+14156605320.0
www.nurixtx.com